| Filed On | Filing |
|---|---|
| 13 Aug 2026 | QUARTERLY REPORT |
| 12 Aug 2026 | SCHEDULE 13G |
| 21 May 2026 | 8-K: Other Events |
| 14 May 2026 | SCHEDULE 13G |
| 13 May 2026 | SCHEDULE 13G |
| 13 May 2026 | QUARTERLY REPORT |
| 22 Apr 2026 | 8-K: Other Events |
| 07 Apr 2026 | SCHEDULE 13G |
| 07 Apr 2026 | 8-K: Other Events |
| 02 Apr 2026 |
Form 4: KPThree Capital Llc, 10% owner and 1 other
Bought 235,000 shares |
| 02 Apr 2026 | 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +4 more |
| 01 Apr 2026 | PROSPECTUS |
| 30 Mar 2026 | EFFECT |
| 30 Mar 2026 | Form 3: Philips Kathleen, Director |
| 30 Mar 2026 | Form 3: Youngblood Dr Kneeland, Director |
| 30 Mar 2026 | Form 3: Kpet Ultra Paceline Llc, 10% owner and 3 others |
| 30 Mar 2026 | Form 3: McKee James, Director |
| 30 Mar 2026 | NYSE CERTIFICATION |
| 30 Mar 2026 | FOR REGISTRATION OF CERTAIN CLASSES |
| 26 Mar 2026 | CORRESP |
Loading...
